3rd Quarter - Report
SONORAN POLICY GROUP, LLC D/B/A STRYK GLOBAL DIPLOMACY, FORMERLY KNOWN AS SONORA for HORIZON THERAPEUTICS (F/K/A) HORIZON PHARMA USA INC
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Federal pharmaceutical regulation
Foreign entity interest: Horizon Therapeutics is a domestic subsidiary of a foreign-parent. Although efforts are not controlled or financed by the foreign parent, all lobbying benefits the foreign parent tangentially.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTIAN BOURGE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.